Avantax Advisory Services Inc. Boosts Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Avantax Advisory Services Inc. lifted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 19.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,039 shares of the company’s stock after purchasing an additional 2,474 shares during the quarter. Avantax Advisory Services Inc.’s holdings in Privia Health Group were worth $338,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. CWM LLC grew its holdings in shares of Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after acquiring an additional 604 shares during the period. Bessemer Group Inc. grew its holdings in shares of Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock worth $51,000 after acquiring an additional 2,178 shares during the period. GAMMA Investing LLC grew its holdings in shares of Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after acquiring an additional 1,521 shares during the period. Financial Management Professionals Inc. grew its holdings in shares of Privia Health Group by 28.7% in the first quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company’s stock worth $76,000 after acquiring an additional 754 shares during the period. Finally, Quadrant Capital Group LLC grew its holdings in shares of Privia Health Group by 11.8% in the fourth quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after acquiring an additional 511 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on PRVA. JMP Securities reaffirmed a “market outperform” rating and issued a $29.00 price objective on shares of Privia Health Group in a report on Monday, April 28th. Truist Financial lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Thursday, April 10th. Barclays lifted their price objective on Privia Health Group from $23.00 to $24.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 27th. Robert W. Baird boosted their price target on Privia Health Group from $24.00 to $26.00 and gave the company an “outperform” rating in a report on Tuesday, April 15th. Finally, Needham & Company LLC reissued a “buy” rating and set a $30.00 price target on shares of Privia Health Group in a report on Thursday, April 10th. One analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $28.38.

Privia Health Group Stock Down 1.4%

NASDAQ PRVA opened at $19.51 on Friday. The firm has a market cap of $2.38 billion, a price-to-earnings ratio of 162.60, a price-to-earnings-growth ratio of 3.16 and a beta of 0.80. The business has a 50-day moving average price of $21.35 and a 200-day moving average price of $22.83. Privia Health Group, Inc. has a twelve month low of $16.47 and a twelve month high of $26.09.

Insider Transactions at Privia Health Group

In other news, CFO David Mountcastle sold 3,322 shares of the company’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $24.99, for a total value of $83,016.78. Following the completion of the transaction, the chief financial officer owned 172,909 shares of the company’s stock, valued at $4,320,995.91. This represents a 1.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Parth Mehrotra sold 13,773 shares of the company’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $24.99, for a total value of $344,187.27. Following the completion of the transaction, the chief executive officer directly owned 423,143 shares of the company’s stock, valued at approximately $10,574,343.57. This trade represents a 3.15% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 10.70% of the company’s stock.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.